Australia's 4DMedical surges on US FDA nod for its CT:VQ scan

4DMedical

01/09/2025 02:42

** 4Dmedical 4DX.AX surges as much as 40.4% to A$0.800, highest since March 12, 2024

** Stock top gainer on ASX All Ordinaries index .AORD

** Medical tech co receives U.S. FDA clearance for its ventilation-perfusion scan CT:VQ

** VQ scan evaluates both airflow and blood flow in the lungs and is primarily used to diagnose pulmonary embolism

** Co's CT:VQ test capable of extracting VQ data from routine CT scans without contrast dyes

** YTD, 4DX gains more than 61%

 (Reporting by Komal Pooja  Asokan)

 ((KomalPooja.Asokan@thomsonreuters.com;))